Study to Evaluate the Safety and Efficacy of ASC40 Tablets in Combination With Bevacizumab in Subjects With rGBM
Clinical trial NCT05118776 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05118776
- Sponsor
- Ascletis Pharmaceuticals Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-21
- Primary completion
- 2025-06-01
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.